Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Potomac Urology’s Dr. John Klein Reaches Milestone of Treating 100 Patients with Rezūm® System Minimally Invasive BPH Therapy
  • USA - English


News provided by

Bellmont Partners

Aug 08, 2017, 12:10 ET

Share this article

Share toX

Share this article

Share toX

Urologist Dr. John Klein
Urologist Dr. John Klein

Alexandria, VA (PRWEB) August 08, 2017 -- Potomac Urology announced today that Dr. John Klein has treated 100 patients with the Rezūm® System, providing improved quality of life for men suffering from lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH), or enlarged prostate. The Rezūm System is an innovative, safe and effective minimally invasive treatment option for men suffering from BPH that does not require general anesthesia and provides an alternative to a lifetime of taking BPH medications. Dr. Klein, a board-certified urologist, offers Rezūm as an in-office BPH treatment option at Potomac Urology in Alexandria and Woodbridge, Va., and is dedicated to bringing his patients new BPH therapies that preserve sexual function and offer a rapid return to normal activities. A native of Arlington, Dr. Klein has been serving patients at Potomac Urology for six years. He attended medical school at the University of Virginia and completed his urology residency at Cleveland Clinic. Dr. Klein specializes in treating patients suffering from voiding dysfunction and BPH, and was recognized as a Top Doctor for two consecutive years by Northern Virginia Magazine.

BPH, or an enlarged prostate gland, is one of the top 10 most common and costly diseases affecting 12 million men aged 50 or more years old in the U.S. BPH causes significant quality of life issues including lack of sleep, anxiety, challenges with sexual function and limits to daily activities.

“My experience treating 100 patients with Rezūm has been excellent, with results including resuming daily activities and sleep with minimal interruption, getting off a lifetime of BPH medications and avoiding other more invasive treatments,” said Dr. Klein. “Results have shown an extremely low risk of side effects, and when I see my patients during their follow-up visits they let me know how happy they are to have regained their quality of life.”

Developed by NxThera, Rezūm is performed in a clinic or out-patient setting. Rezūm uses the natural thermal energy stored in water vapor, or steam, to treat the extra prostate tissue that is causing BPH symptoms such as frequency, urgency, irregular flow, weak stream, straining and getting up at night to urinate. The water vapor is delivered into the targeted prostate tissue and when the vapor contacts the tissue it turns back into water, releasing the stored thermal energy, causing the obstructive prostate tissue cells to die. Over the next few weeks, the body’s natural healing response removes the dead cells, shrinking the prostate. With the extra tissue removed, the urethra opens, reducing BPH symptoms and improving patients’ quality of life. Studies have shown that the Rezūm treatment allows men to retain sexual function unlike many other existing BPH treatments, which typically have higher incidences of long-term side effects. To date, more than 15,000 men have been effectively treated with the Rezūm System across the U.S. and Europe.

“During my first meeting with Dr. Klein, he explained the pros and cons of each treatment option for BPH, and I was relieved that there were alternatives to invasive surgery,” said Potomac Urology patient Maurice McKinney. “I researched the alternatives and found that some procedures would not last and have to be redone. Not seeing that in the Rezūm reviews, that was the treatment I chose. The results are better than I could have hoped. Now I’m free to do all the things I was reluctant to do, because of the effects of BPH. I made the right decision at the right time, for me.”

“Our goal is to transform the lives of BPH patients across the country with the Rezūm System,” said Bob Paulson, president and CEO of NxThera. “With Dr. Klein’s expertise and advanced training with Rezūm, patients suffering from BPH in the Alexandria area now have a minimally invasive, lasting and cost-effective alternative for the treatment of BPH so they can get back to enjoying a better quality of life."

Highlights of the Rezūm therapy include:

  • Performed in-office and patients can return home immediately.
  • Does not require general anesthesia.
  • Relieves symptoms safely and effectively.
  • Is an alternative to BPH medications, eliminating the need for long-term BPH medication use.
  • Provides noticeable symptom improvement within two weeks.
  • Preserves erectile and urinary functions.
  • Allows patients to return to regular activities within a few days.

Patients interested in a consultation with Dr. Klein should call 703-680-2111 or visit http://www.potomacurology.com/appointment.html to schedule an appointment.

For more information about Potomac Urology, visit http://www.potomacurology.com. For more information about the Rezūm System, visit http://www.Rezūm.com or call 888-319-9691.

###

About Potomac Urology
At Potomac Urology, patients receive personalized, state-of-the-art urology treatment with exceptional care and compassion. Potomac Urology providers bring a combination of expertise, innovation, and skill to partner with patients so they may achieve the best possible outcomes. The practice’s urologists bring extensive clinical experience along with unique fellowship certifications in urologic subspecialties by training at the leading urology programs in the country. For more information, visit http://www.potomacurology.com or call 703-680-2111.

About NxThera and the Rezūm System
NxThera pioneered its convective radiofrequency thermal therapy platform technology to treat a variety of endourological conditions, beginning with BPH. The company is furthering the application of the technology platform through advanced research and development targeting the treatment of prostate cancer and kidney cancer. NxThera’s FDA-cleared Rezūm System is a next-generation transurethral needle ablation system indicated to treat symptoms of BPH using radiofrequency energy that is convectively delivered to obstructive prostate tissue in targeted, precise thermal energy treatments, with minimal discomfort. Rezūm treatments provide improvements in BPH symptoms, urine flow and quality of life. Founded in 2008, NxThera is located in Maple Grove, Minn. For more information, visit http://www.Rezūm.com.

Shelli Lissick, Bellmont Partners, 651-276-6922, [email protected]

Modal title

Potomac Urology logo
Potomac Urology logo
Potomac Urology logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.